The global Acute Ocular Pain Market encompasses therapeutics—primarily non-steroidal anti-inflammatory drugs (NSAIDs) and specialized pain relief drops—used to manage sudden, temporary pain arising from post-surgical recovery (such as cataract surgery), corneal abrasions, or infectious conditions. The market’s substantial valuation reflects the high volume of ophthalmological proce... https://livepositively.com/unlocking-value-pricing-regulatory-landscape-and-future-forecast-for-the-ocular-bromfenac-market-2025-2032/